Futura Medical Total Liabilities
Futura Medical total liabilities. Based on the latest financial reports, Futura Medical (FUM) has total liabilities worth GBX2.41 Million GBX (≈ $293.69 USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check Futura Medical (FUM) liquid assets ratio to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Futura Medical (2001–2025)
Total liabilities of Futura Medical from 2001 to 2025. This chart illustrates how Futura Medical's total liabilities have evolved over time, based on quarterly financial data.
Futura Medical Competitors by Total Liabilities
The table below lists competitors of Futura Medical ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
MediaZest plc
LSE:MDZ
|
UK | GBX3.11 Million |
|
Ordinary Fully Paid Deferred Settlement
AU:BCNDA
|
Australia | AU$49.41 Million |
|
Eenergy Group PLC
LSE:EAAS
|
UK | GBX23.52 Million |
|
Distil Plc
LSE:DIS
|
UK | GBX951.00K |
|
SRAX Inc
NASDAQ:SRAX
|
USA | $27.32 Million |
|
Eos Energy Enterprises Inc
NASDAQ:EOSEW
|
USA | $2.65 Billion |
|
t42 IoT Tracking Solutions PLC
LSE:TRAC
|
UK | GBX6.75 Million |
Liability Composition Analysis (2001–2025)
This chart breaks down Futura Medical's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see total assets of Futura Medical.
Liquidity & Leverage Metrics
Futura Medical Total Liabilities Ratios Explained
Futura Medical total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.06 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.86 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.46 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Futura Medical's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Futura Medical (2001–2025)
The table below shows the annual total liabilities of Futura Medical from 2001 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | GBX2.41 Million ≈ $293.69 |
-47.84% |
| 2024-12-31 | GBX4.63 Million ≈ $563.01 |
-27.01% |
| 2023-12-31 | GBX6.34 Million ≈ $771.34 |
+261.62% |
| 2022-12-31 | GBX1.75 Million ≈ $213.30 |
-15.64% |
| 2021-12-31 | GBX2.08 Million ≈ $252.85 |
+171.12% |
| 2020-12-31 | GBX766.52K ≈ $93.26 |
-84.19% |
| 2019-12-31 | GBX4.85 Million ≈ $589.80 |
+139.32% |
| 2018-12-31 | GBX2.03 Million ≈ $246.45 |
+305.80% |
| 2017-12-31 | GBX499.14K ≈ $60.73 |
-41.63% |
| 2016-12-31 | GBX855.18K ≈ $104.05 |
+17.29% |
| 2015-12-31 | GBX729.12K ≈ $88.71 |
+19.94% |
| 2014-12-31 | GBX607.89K ≈ $73.96 |
+27.17% |
| 2013-12-31 | GBX478.00K ≈ $58.16 |
+42.71% |
| 2012-12-31 | GBX334.95K ≈ $40.75 |
+72.66% |
| 2011-12-31 | GBX194.00K ≈ $23.60 |
+27.63% |
| 2010-12-31 | GBX152.00K ≈ $18.49 |
-32.14% |
| 2009-12-31 | GBX224.00K ≈ $27.25 |
+47.37% |
| 2008-12-31 | GBX152.00K ≈ $18.49 |
-51.75% |
| 2007-12-31 | GBX315.00K ≈ $38.33 |
+33.47% |
| 2006-12-31 | GBX236.00K ≈ $28.71 |
-0.42% |
| 2005-12-31 | GBX237.00K ≈ $28.84 |
+5.33% |
| 2004-12-31 | GBX225.00K ≈ $27.38 |
+25.00% |
| 2003-12-31 | GBX180.00K ≈ $21.90 |
-27.13% |
| 2003-01-31 | GBX247.00K ≈ $30.05 |
-5.73% |
| 2002-01-31 | GBX262.00K ≈ $31.88 |
-58.41% |
| 2001-01-31 | GBX630.00K ≈ $76.65 |
-- |
About Futura Medical
Futura Medical plc research, develops, and commercializes pharmaceutical and healthcare products for sexual health. The company's lead product includes Eroxon, a topical gel for the treatment of erectile dysfunction. It also develops WSD4000 for the treatment of sexual dysfunction in women. The company operates in the United Kingdom, the European Union, the United States, and internationally. Fut… Read more